메뉴 건너뛰기




Volumn 13, Issue 2, 2008, Pages 83-85

Unraveling the Complexity of Endocrine Resistance in Breast Cancer by Functional Genomics

Author keywords

[No Author keywords available]

Indexed keywords

5 (4 BROMO 2 CHLOROANILINO) 4 FLUORO 1 METHYL 1H BENZIMIDAZOLE 6 CARBOHYDROXAMIC ACID 2 HYDROXYETHYL ESTER; BIOLOGICAL MARKER; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 10; ERLOTINIB; EVEROLIMUS; GEFITINIB; LAPATINIB; MITOGEN ACTIVATED PROTEIN KINASE; N (2,3 DIHYDROXYPROPOXY) 3,4 DIFLUORO 2 (2 FLUORO 4 IODOANILINO)BENZAMIDE; RAPAMYCIN; TAMOXIFEN; TEMSIROLIMUS; TRASTUZUMAB; UNCLASSIFIED DRUG;

EID: 38549087008     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2008.01.021     Document Type: Short Survey
Times cited : (10)

References (12)
  • 2
    • 19344364880 scopus 로고    scopus 로고
    • Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
    • Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Lancet 365 (2005) 1687-1717
    • (2005) Lancet , vol.365 , pp. 1687-1717


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.